Clinicopathologic Analysis of Primary Adrenal Diffuse Large B-Cell Lymphoma

淋巴瘤 弥漫性大B细胞淋巴瘤 医学 美罗华 免疫组织化学 病理 内科学 胃肠病学
作者
Tasuku Kawano,Yuta Tsuyuki,Yuka Suzuki,Kazuyuki Shimada,Seiichi Kato,Taishi Takahara,Mayuko Mori,Masato Nakaguro,Ayako Sakakibara,Shigeo Nakamura,Akira Satou
出处
期刊:The American Journal of Surgical Pathology [Ovid Technologies (Wolters Kluwer)]
卷期号:45 (12): 1606-1615 被引量:8
标识
DOI:10.1097/pas.0000000000001809
摘要

Primary adrenal diffuse large B-cell lymphoma (PA-DLBCL) is rare. We investigate 23 Japanese patients with PA-DLBCL to understand the clinicopathologic features and biological behavior of this disease. The 17 males and 6 females had a median age of 74 years (range: 40 to 86 y). Tumor cells harbored Epstein-Barr virus–encoded small RNA (EBER) in 9 (39%) samples, including samples from the 2 patients with methotrexate-associated B-cell lymphoproliferative disorder. Programmed cell death ligand 1 (PD-L1) expression was detected in tumor cells of 6 (26%) samples, including 1 EBER + and 5 EBER − samples. Four (17%) patients exhibited an intravascular proliferating pattern, and all 4 patient samples showed positive staining for PD-L1 in tumor cells. Among those patients, 3 showed intravascular proliferating pattern accompanied by a diffuse extravascular proliferation of tumor cells, and 1 patient was diagnosed with intravascular large B-cell lymphoma. We divided the 23 patients into 3 groups: EBER + (n=9, 39%), EBER − PD-L1 + (n=5, 22%), and EBER − PD-L1 − (n=9, 39%). A comparison of the outcomes among the 3 groups showed significant differences in overall survival ( P =0.034). The EBER + group had the worst prognosis, and the EBER − PD-L1 − group had the best prognosis. We also compared the outcomes among the 3 groups that received rituximab-containing chemotherapies. Both the overall survival and progression-free survival were significantly different among these groups ( P <0.001 and P =0.002, respectively). In conclusion, we evaluated 3 types of PA-DLBCL and found that each had unique clinical, pathologic, and prognostic features. Our results suggested that immune senescence, iatrogenic immunodeficiency, and immune evasion contribute to the development of PA-DLBCL.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
慕青应助卡卡罗特采纳,获得10
刚刚
刚刚
深情映冬发布了新的文献求助10
1秒前
2秒前
2秒前
fwz完成签到,获得积分10
3秒前
aaaxie发布了新的文献求助10
5秒前
深情映冬完成签到,获得积分20
6秒前
SciGPT应助Wt采纳,获得10
6秒前
Ran完成签到,获得积分20
6秒前
7秒前
7秒前
fwz发布了新的文献求助10
8秒前
Grinder驳回了Apple应助
10秒前
乐乐应助笨笨西装采纳,获得10
12秒前
缥缈青文发布了新的文献求助10
12秒前
大模型应助无辜善愁采纳,获得10
12秒前
橙橙妈妈发布了新的文献求助20
12秒前
FashionBoy应助丰富的不惜采纳,获得10
13秒前
14秒前
江夏完成签到,获得积分20
14秒前
15秒前
田様应助ballball了采纳,获得10
17秒前
JasonSun完成签到,获得积分10
18秒前
19秒前
19秒前
19秒前
Only发布了新的文献求助10
20秒前
20秒前
WLX发布了新的文献求助10
21秒前
tonyhuang完成签到,获得积分10
21秒前
胡小壳应助科研通管家采纳,获得10
22秒前
Hello应助科研通管家采纳,获得10
22秒前
搜集达人应助科研通管家采纳,获得30
22秒前
华仔应助科研通管家采纳,获得10
22秒前
脑洞疼应助科研通管家采纳,获得10
22秒前
orixero应助科研通管家采纳,获得10
22秒前
Lucas应助科研通管家采纳,获得10
22秒前
缥缈青文完成签到,获得积分10
22秒前
汉堡包应助科研通管家采纳,获得10
22秒前
高分求助中
Sustainability in Tides Chemistry 2000
Microlepidoptera Palaearctica, Volumes 1 and 3 - 13 (12-Volume Set) [German] 1122
Дружба 友好报 (1957-1958) 1000
The Data Economy: Tools and Applications 1000
A Dissection Guide & Atlas to the Rabbit 600
中国心血管健康与疾病报告2023(要完整的报告) 500
Development of a new synthetic process for the synthesis of (S)-methadone and (S)- and (R)-isomethadone as NMDA receptor antagonists for the treatment of depression 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3102795
求助须知:如何正确求助?哪些是违规求助? 2754032
关于积分的说明 7626280
捐赠科研通 2406879
什么是DOI,文献DOI怎么找? 1277068
科研通“疑难数据库(出版商)”最低求助积分说明 617041
版权声明 599103